Literature DB >> 19204156

Rapidly progressive neurodegenerative dementias.

Keith A Josephs1, J Eric Ahlskog, Joseph E Parisi, Bradley F Boeve, Brian A Crum, Caterina Giannini, Ronald C Petersen.   

Abstract

BACKGROUND: Neurodegenerative dementias are typically characterized by an insidious onset and a relatively slowly progressive course. Less common are patients with a rapidly progressive course to death.
OBJECTIVE: To characterize patients with a neurodegenerative disease and a rapidly progressive course to death. DESIGN, SETTING, AND PATIENTS: Using a text word search for "rapid" and "dementia" in the same sentence, the Mayo Clinic Medical Records Linkage system was used to identify all patients evaluated between January 1, 2000, and September 30, 2007, with brain autopsy (N = 96) at a tertiary care medical center. Of these 96 patients, we included only those with disease duration of less than 4 years to death and with histological diagnosis of a neurodegenerative disease. MAIN OUTCOME MEASURES: Rapidly progressive dementia with death sooner than 4 years after onset and pathological diagnosis at our institution of a neurodegenerative disease.
RESULTS: We included 22 patients (10 men). Although 8 cases (36%) had Creutzfeldt-Jakob disease (CJD), the rest had frontotemporal lobar degeneration with motor neuron degeneration (5 cases [23%]), a tauopathy (progressive supranuclear palsy or corticobasal degeneration) (4 cases [18%]), diffuse Lewy body disease (3 cases [14%]), or Alzheimer disease (2 cases [9%]). All of the patients with CJD died 12 months or sooner after onset, whereas the others had an illness duration longer than 12 months. Notably, all of the 3 patients with diffuse Lewy body disease but no others initially experienced a transient postoperative or illness-associated encephalopathy, then relative normality for 2 years, and finally a rapidly progressive dementia and decline to death in 4 to 12 months.
CONCLUSIONS: Based on this cohort, although CJD is the most likely cause of a rapidly progressive neurodegenerative dementia, frontotemporal lobar degeneration with motor neuron degeneration, diffuse Lewy body disease, tauopathies, and Alzheimer disease can also cause a rapidly progressive dementia. If illness duration is beyond 12 months, a non-CJD neurodegenerative disease may be more likely than CJD to be the diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 19204156      PMCID: PMC2764283          DOI: 10.1001/archneurol.2008.534

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

1.  Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

Authors:  Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

2.  Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND.

Authors:  K A Josephs; D S Knopman; J L Whitwell; B F Boeve; J E Parisi; R C Petersen; D W Dickson
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

3.  Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease.

Authors:  H J Tschampa; M Neumann; I Zerr; K Henkel; A Schröter; W J Schulz-Schaeffer; B J Steinhoff; H A Kretzschmar; S Poser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

4.  Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.

Authors:  I Zerr; W J Schulz-Schaeffer; A Giese; M Bodemer; A Schröter; K Henkel; H J Tschampa; O Windl; A Pfahlberg; B J Steinhoff; O Gefeller; H A Kretzschmar; S Poser
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

5.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  P Sanchez-Juan; A Green; A Ladogana; N Cuadrado-Corrales; R Sáanchez-Valle; E Mitrováa; K Stoeck; T Sklaviadis; J Kulczycki; K Hess; M Bodemer; D Slivarichová; A Saiz; M Calero; L Ingrosso; R Knight; A C J W Janssens; C M van Duijn; I Zerr
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

6.  Frontotemporal dementia: clinicopathological correlations.

Authors:  Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H Karlawish; Howard J Rosen; Vivianna Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

7.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

8.  The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage.

Authors:  S M Greenberg; J P Vonsattel; J W Stakes; M Gruber; S P Finklestein
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

Review 9.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

10.  Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes.

Authors:  H Braak; E Braak
Journal:  Neurosci Lett       Date:  1987-04-23       Impact factor: 3.046

View more
  37 in total

1.  Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.

Authors:  Jennifer L Whitwell; Jia Xu; Jay N Mandrekar; Jeffrey L Gunter; Clifford R Jack; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2011-11-13       Impact factor: 4.891

2.  Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease.

Authors:  Alberto J Espay; Salvatore Spina; David J Houghton; Jill R Murrell; Gabrielle M de Courten-Myers; Bernardino Ghetti; Irene Litvan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-28       Impact factor: 10.154

3.  Fulminant corticobasal degeneration: Agrypnia excitata in corticobasal syndrome.

Authors:  Federico Rodriguez-Porcel; Lindsey Lowder; Rosa Rademakers; Thomas Ravenscroft; Bernardino Ghetti; Mathew C Hagen; Alberto J Espay
Journal:  Neurology       Date:  2016-02-12       Impact factor: 9.910

4.  Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease.

Authors:  Istvan Kapas; Katalin Majtenyi; Klara Törö; Eva Keller; Till Voigtländer; Gabor G Kovacs
Journal:  Metab Brain Dis       Date:  2012-04-27       Impact factor: 3.584

Review 5.  Rapidly progressive dementias and the treatment of human prion diseases.

Authors:  Brian S Appleby; Constantine G Lyketsos
Journal:  Expert Opin Pharmacother       Date:  2010-11-23       Impact factor: 3.889

6.  Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.

Authors:  Pedro Piccardo; Juraj Cervenak; Ming Bu; Lindsay Miller; David M Asher
Journal:  J Gen Virol       Date:  2014-04-25       Impact factor: 3.891

7.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

Review 8.  The evaluation of rapidly progressive dementia.

Authors:  Michael Henry Rosenbloom; Alireza Atri
Journal:  Neurologist       Date:  2011-03       Impact factor: 1.398

9.  Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia.

Authors:  Carlos Toledano-Illán; Inés Esparragosa Vázquez; María Victoria Zelaya Huerta; Juan José Rosales Castillo; Alberto Paternain Nuin; Javier Arbizu Lostao; María Reyes García de Eulate; Mario Riverol Fernández
Journal:  J Neurol       Date:  2021-02-26       Impact factor: 4.849

10.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.